Avita Medical | 1811094D - Assets



Avita Medical reported AUD79.71M in Assets for its fiscal semester ending in December of 2024.


Assets Change Date
Adcock Ingram Holdings ZAR 8.74B 388.13M Dec/2024
Celltrion KRW 20.96T 96.41B Mar/2025
Clinuvel Pharmaceuticals AUD 231.12M 19.44M Jun/2024
Cochlear AUD 2.79B 41M Dec/2024
CSL USD 38.45B 425M Dec/2024
Cspc Pharmaceutical CNY 44.39B 3.51B Dec/2024
Dianthus Therapeutics USD 326.08M 47.93M Jun/2025
Divis Laboratories Ltd 169.32B 13.46B Mar/2025
Kangmei Pharma CNY 13.64B 69.1M Jun/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 869.6M 37.58M Jun/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Mayne Pharma AUD 1.14B 9.47M Jun/2024
Medical Developments International AUD 65.33M 6.17M Dec/2024
Nanosonics AUD 255.03M 17.69M Dec/2024
Neuren Pharmaceuticals AUD 409.71M 181.55M Dec/2024
Organigram Holdings CAD 564.62M 85.41M Jun/2025
Pacific Edge NZD 37.03M 13.82M Mar/2025
Paradigm Biopharmaceuticals AUD 35.36M 7.97M Dec/2024
Pharma Mar EUR 348.25M 14.75M Jun/2025
Polynovo AUD 108.72M 11.51M Jun/2024
PYC Therapeutics AUD 68.23M 23.01M Dec/2024
Qiagen NV USD 5.82B 278.39M Jun/2025
Ramsay Health Care AUD 20.66B 237M Dec/2024
ResMed USD 8.17B 1.03B Jun/2025
Sartorius EUR 10.03B 85.1M Jun/2025
Sino Biopharmaceutical CNY 65.41B 1.3B Dec/2024
Telix Pharmaceuticals AUD 1.52B 770.47M Dec/2024
Tilray USD 4.19B 70.11M Nov/2024
Zz Pientze Pharmaceu 18.71B 224.21M Jun/2025